A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP asce...

by Tsuburaya Akira, Morita Satoshi, Kodera Yasuhiro, Kobayashi Michiya, Shitara Kohei, Yamaguchi Kensei, Yoshikawa Takaki, Yoshida Kazuhiro, Yoshino Shigefumi, Sakamoto Jun-ichi
Published 2012-07-01